HCPCS Level II · Drugs administered other than oral method
J0350Injection, anistreplase, per 30 units
Terminated 12/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0350
J0350 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, anistreplase, per 30 units.
It was added to HCPCS effective 01/01/1986, and its current record took effect 01/01/2026.
It was terminated on 12/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Injection anistreplase 30 u
- Date added
- 01/01/1986
- Action effective
- 01/01/2026
- Termination date
- 12/31/2025
- BETOS
- O1E
Related J03xx codes
- J0300Injection, amobarbital, up to 125 mg
- J0330Injection, succinylcholine chloride, up to 20 mg
- J0348Injection, anidulafungin, 1 mg
- J0349Injection, rezafungin, 1 mg
- J0360Injection, hydralazine hcl, up to 20 mg
- J0364Injection, apomorphine hydrochloride, 1 mg
- J0390Injection, chloroquine hydrochloride, up to 250 mg
- J0391Injection, artesunate, 1 mg
Common questions about J0350
Is HCPCS J0350 still valid?
- No. J0350 was terminated on 12/31/2025.
Does Medicare cover J0350?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.